Fish oil

Fish oil has been studied in 274 papers since 1988: 127 trials and 45 observational studies in people, 64 in animals, 31 reviews; 22 in the past year. The newest story, Oct 26, 2026: “Fish oil use linked to lower risk of aortic valve narrowing”.

Intervention

274 papers study it529 findingsUpdated

More supplements

5 new papers in 30 daysSee all 274 papers on fish oil

At a glance

A human trial reports fewer strokes and myocardial infarctions in people receiving maintenance hemodialysis. Independent labs report lower triglycerides but higher LDL cholesterol in humans; other trials show no clear triglyceride effect. Sixteen registered trials concern aging; across all uses, 40 ended over a year ago without posted results or linked papers, and 18 have developer sponsors.

529 findings in 201 papers from 1988 to 2026, 7 of them since May 2026

Independent labs found the same change in mice and people. 129 independent labs in 31 countries; 116 trials, 16 about aging, 41 with no results posted.

“After adjusting for confounders, FO supplementation was associated with a lower risk (HR, 0.78; 95% confidence interval (CI), 0.64-0.96) of incident MMD.”
Association of Fish Oil and Physical Activity on Mobility Disability in Older AdultsMedicine and science in sports and exercise2019doi:10.1249/mss.0000000000002195

64 of its findings point the other way.

Mice and humans: replicated by independent labs. Worms or flies: a single group. Cells: nothing yet.
  • 129 independent labs in 31 countries
  • 64 findings against
  • 116 trials, 16 about aging, 41 with no results posted
  • Funders: National Institutes of Health and others
  • 25 of 520 findings with company ties
  • 21 of 116 trials sponsored by its developers
  • Human trial127
  • Humans45
  • Animals63
  • Model organisms1

109 studies gave fish oil to people and measured what changed.

What changedDesignPeopleSource

down: Decreases remnant lipoprotein cholesterol

no change: Has no effect on C-reactive protein

Randomized trial12 weeks240 peoplemiddle-aged and elderlyMidlife adults; Older adultsClinical nutrition (Edinburgh, Scotland), Nov 1, 2026

up: Improves climacteric symptoms-39.19%

down: Decreases body weight-12.9%

down: Decreases HbA1c-13.16%

Randomized trial60 days98 peopleWomen47 ± 2 yearsMidlife adults; perimenopausal women receiving nutritional advice adapted to Mediterranean dietCurrent Women s Health Reviews, Sep 15, 2026

down: Decreases CERT2-2.18, 95% CI -3.15--1.21

Randomized trial20 weeksWithin a structured cardioprotective dietary programJournal of clinical lipidology, Sep 9, 2026

down: Decreases Clinical Dementia Rating

Randomized trial24 weeks14 people55-75 yearsMidlife adults; Older adults; in patients with MCIAntioxidants (Basel, Switzerland), May 6, 2026

up: Increases end-diastolic velocitymean difference 1.95 (0.13, 3.77)

up: Increases peak diastolic velocitymean difference 2.95 (0.48, 5.41)

no change: Has no effect on blood pressure

Randomized trial3-week64 peopleIn the left anterior descending arteryFood & function, Mar 31, 2026

What did lifespan studies of fish oil find?

DrugAge

DrugAge records 3 results from 1 paper: 3 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.

What did studies of fish oil find?

295

Studies of fish oil measured 295 outcomes; the most studied are triglyceride (29 studies), inflammation (14) and oxidative stress and ROS signaling (13).

Triglyceride

downin humans27no changein humans2downin reviews1−37% to −27%

29 studies
  1. Fish oil decreases triglyceride in humans with resistance exercise training.

    Human trialwith resistance exercise training8 wkfemalesn = 20

  2. Fish oil decreases triglyceride in humans (P = 0.012).

    Human trial6 months

  3. Fish oil decreases triglyceride in humans (p < 0.05).

    Human trialEPA-rich (EPA/DHA: 2.3) or DHA-rich (EPA/DHA: 0.3)plasma12 g/day8-weeksn = 30

  4. Fish oil decreases triglyceride in the CRF group, with caloric restriction.

    Human trialin the CRF group, with caloric restrictionplasma12 weeksmalesn = 9

  5. Fish oil decreases triglyceride in humans during resistance exercise training; compared with placebo.

    Human trialduring resistance exercise training; compared with placeboplasma3 g/day18 weeksn = 50

  6. Fish oil decreases triglyceride in humans.

    Human trial12 weeksfemales

  7. Fish oil decreases triglyceride in humans (-29%).

    Human trial3g/d12 wkfemalesn = 24

  8. Fish oil decreases triglyceride in rs741038 C/C homozygotes with carbohydrate intake >48.59%.

    Human trialin rs741038 C/C homozygotes with carbohydrate intake >48.59%1.9-2.2 g EPA and 1.1 g DHA5 g/day6 weeksn = 208

  9. Fish oil decreases triglyceride in humans (P=0.0006).

    Human trialserum3-monthmalesn = 10

  10. Fish oil decreases triglyceride in the "d5" ALOX5 genotype.

    Human trialin the "d5" ALOX5 genotype5 g/d (2 g EPA, 1 g DHA)

All 32

More on Triglyceride

Inflammation

no changein humans4downin humans3downin rats3downin mice2+2

14 studies
  1. Fish oil decreases inflammation in humans with resistance exercise training.

    Human trialwith resistance exercise training8 wkfemalesn = 20

  2. Fish oil showed no clear effect on inflammation in humans (resistance training).

    Human trialresistance training98 daysfemalesn = 34

  3. Fish oil decreases inflammation in humans (against PM2.5 exposure).

    Human trialagainst PM2.5 exposure2.5 g/daySeptember 2017 to January 2018n = 65

  4. Fish oil showed no clear effect on inflammation in humans (Mdiff -0.04 pg/mL, 95% CI -0.27, 0.19).

    Human trial18 weeksn = 272

  5. Fish oil showed no clear effect on inflammation in humans (healthy) (P ≥ 0.20).

    Human trialhealthy1400 mg per day EPA+DHA18 weeks

  6. Fish oil showed no clear effect on inflammation in humans (overweight subjects).

    Human trialoverweight subjects2 g/day (1.1 g marine n-3 PUFA)6 weeksn = 50

  7. Fish oil showed no clear effect on inflammation in humans.

    Human trialserum3.5 g/day (1.5 g/day total n-3 PUFA)12 weeksn = 77

  8. Fish oil inhibits inflammation in humans (healthy).

    Human trialhealthycapsulesperipheral blood mononuclear cells1.8 g/d26 wk

  9. Fish oil decreases inflammation in aging-related depression model.

    Animalsin aging-related depression modelbrainmales

  10. Fish oil decreases inflammation in mice (surgical).

    Animalssurgicaloral gavageprefrontal cortex and hippocampus300 mg/kg3 weeks

All 15

More on Inflammation

Oxidative stress and ROS signaling

upin humans4downin mice4downin humans2no changein humans1+2

13 studies
  1. Fish oil decreases oxidative stress and ROS signaling in humans with resistance exercise training.

    Human trialwith resistance exercise training8 wkfemalesn = 20

  2. Fish oil decreases oxidative stress and ROS signaling in humans (against PM2.5 exposure).

    Human trialagainst PM2.5 exposure2.5 g/daySeptember 2017 to January 2018n = 65

  3. Fish oil increases oxidative stress and ROS signaling in humans.

    Human trial2.3 g daily18 mo

  4. Fish oil increases oxidative stress and ROS signaling in humans.

    Human trialcontaining 26% eicosapentaenoic acid (EPA, 20:5, n-3) and 54% DHA (22:6, n-3)neutrophils3g/day2 monthsmalesn = 10

  5. Fish oil increases oxidative stress and ROS signaling in humans (healthy volunteers).

    Human trialhealthy volunteers25 g/d30 daysn = 10

  6. Fish oil showed no clear effect on oxidative stress and ROS signaling in humans (copper-catalyzed oxidation of LDL) (total volatiles remained unchanged).

    Human trialcopper-catalyzed oxidation of LDLn = 9

  7. Fish oil increases oxidative stress and ROS signaling in humans.

    Human trialcapsulesplasma2 mofemales

  8. Fish oil decreases oxidative stress and ROS signaling in mice (surgical).

    Animalssurgicaloral gavageprefrontal cortex and hippocampus300 mg/kg3 weeks

  9. Fish oil decreases oxidative stress and ROS signaling in rats (compared to lard diet) (P < 0.05).

    Animalscompared to lard dietliver3 monthsmales

  10. Fish oil increases oxidative stress and ROS signaling in SAMP8 mice.

    Animalsin SAMP8 mice5% fish oil and 5% safflower oil28 wkmales

All 13

More on Oxidative stress and ROS signaling

Lifespan

upin mice8no changein mice2downin mice2upin reviews1−9.8% median lifespan

12 studies
  1. Fish oil showed no clear effect on lifespan in genetically heterogeneous mice.

    Reviewin genetically heterogeneous micelow or high dosages

  2. Fish oil shortens lifespan in mice (-9.8% median lifespan).

    Animals4.40 g/kg dietmales

  3. Fish oil extends lifespan in mice (lupus-prone (NZBxNZW)F1 mice, compared with standard chow) (median 410 d vs 301 d on standard chow).

    Animalslupus-prone (NZBxNZW)F1 mice, compared with standard chowFO-18/12 (18-EPA/12-DHA)4%

  4. Fish oil extends lifespan in mice (lupus-prone (NZBxNZW)F1 mice) (517 d).

    Animalslupus-prone (NZBxNZW)F1 miceconcentrated, FDA-approved (Lovaza)1%

  5. Fish oil extends lifespan in mice (lupus-prone (NZBxNZW)F1 mice) (median 502 d; maximal 600 d).

    Animalslupus-prone (NZBxNZW)F1 miceconcentrated, FDA-approved (Lovaza)4%

  6. Fish oil showed no clear effect on lifespan in SAMP8 mice.

    Animalsin SAMP8 mice5% fish oil and 5% safflower oillong-termmales

  7. Fish oil shortens lifespan in SAMP8 mice.

    Animalsin SAMP8 mice5% fish oil and 5% safflower oillong-termmales

  8. Fish oil extends lifespan in mice (ad-libitum feeding in NZB x NZW F1 mice, compared with corn oil).

    Reviewad-libitum feeding in NZB x NZW F1 mice, compared with corn oiln-3 fatty acids

  9. Fish oil extends lifespan in B/W mice.

    Animalsin B/W mice

  10. Fish oil extends lifespan in food-restricted mice (median life span 645 d vs 494 d).

    Animalsin food-restricted micefish oil substituted for corn oil

All 15

Total cholesterol

no changein humans3downin humans2upin humans1downin rats1−27%

7 studies
  1. Fish oil decreases total cholesterol in humans (perimenopausal women receiving nutritional advice adapted to Mediterranean diet) (-26.86%).

    Human trialperimenopausal women receiving nutritional advice adapted to Mediterranean dietfish oil1g per day60 daysfemalesn = 98

  2. Fish oil decreases total cholesterol in humans (participants with lower adiponectin concentration at baseline).

    Human trialparticipants with lower adiponectin concentration at baselineserum3 g/d2-mo

  3. Fish oil increases total cholesterol in apoE4 carriers relative to common E3/E3 genotype.

    Human trialin apoE4 carriers relative to common E3/E3 genotypecapsules3.0 g eicosapentaenoic acid/docosahexaenoic acid per day6 weeksmales

  4. Fish oil showed no clear effect on total cholesterol in humans (treated hypertensives).

    Human trialtreated hypertensivescapsules (Lipitac)plasma15 g/day8 weeksn = 20

  5. Fish oil showed no clear effect on total cholesterol in humans (mild non-insulin-dependent diabetes mellitus).

    Human trialmild non-insulin-dependent diabetes mellitus10 g daily3 wkn = 10

  6. Fish oil decreases total cholesterol in rats (significantly reduced in both fish oil groups vs corn oil groups; p < 0.001).

    Animals2.8 g/kg body weight4 monthsfemales

  7. Fish oil showed no clear effect on total cholesterol in humans (hyperlipidemic subjects) (-0.01 mmol/L, 95% CI: -0.03 to 0.01).

    Reviewhyperlipidemic subjects3.25 g daily

More on Total cholesterol

IL-6

no changein humans3downin humans3downin rats1

7 studies
  1. Fish oil showed no clear effect on IL-6 in humans (change compared with corn oil control group) (-0.66 ± 1.05 vs. -0.25 ± 0.94).

    Human trialchange compared with corn oil control groupenriched with EPA and DHA2 g day-1 EPA + DHA90 days

  2. Fish oil decreases IL-6 in humans (LPS-stimulated production).

    Human trialLPS-stimulated production

  3. Fish oil showed no clear effect on IL-6 in humans (log-transformed plasma IL-6) (difference of means -0.020 ± 0.077 (SE); 95% CI -0.171 to 0.132; p = .80).

    Human triallog-transformed plasma IL-61,400-2,800 mg/d12 months

  4. Fish oil decreases IL-6 in humans (compared with calorie-restricted diet with meal replacement alone) (mean IL-6 reduction 35% (CRMRF) vs 21% (CRMR)).

    Human trialcompared with calorie-restricted diet with meal replacement alone12 weeks

  5. Fish oil showed no clear effect on IL-6 in humans (nondialysis CKD) (P = .453, P = .242).

    Human trialnondialysis CKD2.4 g/day8 weeksn = 31

  6. Fish oil decreases IL-6 in rats (strongest difference in non-ovariectomized rats) (highly significant; p < 0.001).

    Animalsstrongest difference in non-ovariectomized rats2.8 g/kg body weight4 monthsfemales

  7. Fish oil decreases IL-6 in patients with chronic heart failure (SMD = -0.81, 95% CI -1.48 to -0.14, p = 0.02).

    Reviewin patients with chronic heart failure

More on IL-6

Blood pressure

no changein humans7

7 studies
  1. Fish oil showed no clear effect on blood pressure in humans (moderate risk of CVD).

    Human trialmoderate risk of CVD1.5 g LC n-3 PUFAs/d8-wkn = 84

  2. Fish oil showed no clear effect on blood pressure in humans.

    Human trial5 g/d (2 g EPA, 1 g DHA)

  3. Fish oil showed no clear effect on blood pressure in overweight hypertensive patients.

    Human trialin overweight hypertensive patientscapsules3 g day(-1)8 weeksn = 52

  4. Fish oil showed no clear effect on blood pressure in humans (responses to physiological stressors).

    Human trialresponses to physiological stressors1 monthn = 9

  5. Fish oil showed no clear effect on blood pressure in hypertensives treated with ACE inhibitors.

    Human trialin hypertensives treated with ACE inhibitorssix week

  6. Fish oil showed no clear effect on blood pressure in humans.

    Human trial12 wkmalesn = 45

  7. Fish oil showed no clear effect on blood pressure in humans (treated hypertensives).

    Human trialtreated hypertensivescapsules (Lipitac)15 g/day8 weeksn = 20

LDL cholesterol

upin humans7+8.5%

7 studies
  1. Fish oil increases LDL cholesterol in humans (hypertriglyceridemic adults) (+13 ± 3% (+0.31 ± 0.08 mmol/L), p < 0.0001).

    Human trialhypertriglyceridemic adultsEPA + DHA4 g/d12 weeksn = 42

  2. Fish oil increases LDL cholesterol in humans (patients receiving antiretrovirals with fasting triglyceride levels >200 mg/dL) (+22.4% (95% CI, +7.91% to +36.8%)).

    Human trialpatients receiving antiretrovirals with fasting triglyceride levels >200 mg/dL16 weeks

  3. Fish oil increases LDL cholesterol in humans (moderate hypercholesterolemia) (+8.5%).

    Human trialmoderate hypercholesterolemiaserum12 g/d12 wkmalesn = 50

  4. Fish oil increases LDL cholesterol in humans (both groups, initially low LDL cholesterol).

    Human trialboth groups, initially low LDL cholesterolplasma6 g/day omega-3 fatty acids12 weeksn = 9

  5. Fish oil increases LDL cholesterol in humans (Isolated hypercholesterolemia; compared with safflower oil placebo) (4.5 versus 4.1 mmol/L with placebo).

    Human trialIsolated hypercholesterolemia; compared with safflower oil placebocapsulestwenty 1-g capsules12 weeksmalesn = 38

  6. Fish oil increases LDL cholesterol in humans (hyperlipidemic subjects) (0.06 mmol/L, 95% CI: 0.03 to 0.09).

    Reviewhyperlipidemic subjects3.25 g daily

  7. Fish oil increases LDL cholesterol in type 2 diabetes (0.21 mmol/l [0.02 to 0.41]).

    Reviewin type 2 diabetes3 to 18 g/daymean of 12 weeksn = 823

More on LDL cholesterol

C-reactive protein

no changein humans3downin humans3

6 studies
  1. Fish oil showed no clear effect on C-reactive protein in humans.

    Human trialEPA+DHA formulation12 weeksn = 240

  2. Fish oil decreases C-reactive protein in humans (change compared with corn oil control group) (-0.85 ± 2.49 vs. 0.56 ± 2.14).

    Human trialchange compared with corn oil control groupenriched with EPA and DHA2 g day-1 EPA + DHA90 days

  3. Fish oil showed no clear effect on C-reactive protein in humans (Mdiff 0.05 mg/L, 95% CI -0.24, 0.19).

    Human trial18 weeksn = 272

  4. Fish oil showed no clear effect on C-reactive protein in humans (healthy) (P ≥ 0.20).

    Human trialhealthy1400 mg per day EPA+DHA18 weeksn = 261

  5. Fish oil decreases C-reactive protein in patients with end-stage renal disease (from pretest 16 mg/dL to posttest 10.22 mg/dL).

    Human trialin patients with end-stage renal disease960 mg/d EPA and 600 mg/d DHA6 monthsn = 33

  6. Fish oil decreases C-reactive protein in haemodialysis patients (-3.3 +/- 8.1 mg/l, P = 0.0282).

    Human trialin haemodialysis patients1.3 g of EPA + DHA daily12 weeksn = 27

  7. Fish oil showed no clear effect on C-reactive protein in humans (healthy subjects and patients with CAD).

    Human trialhealthy subjects and patients with CAD1.5 g/day and 3 g/day

More on C-reactive protein

TNF-alpha

downin humans4downin mice1

5 studies
  1. Fish oil decreases TNF-alpha in humans (change compared with corn oil control group) (-1.87 ± 2.71 vs. -0.64 ± 2.62).

    Human trialchange compared with corn oil control groupenriched with EPA and DHA2 g day-1 EPA + DHA90 days

  2. Fish oil decreases TNF-alpha in humans (combined with strength training (ST150 group), base to post-test).

    Human trialcombined with strength training (ST150 group), base to post-test2 g/d60 d then 90 dfemalesn = 15

  3. Fish oil decreases TNF-alpha in humans.

    Human trial12 weeksn = 50

  4. Fish oil decreases TNF-alpha in humans (normoglycemic offspring of patients with type 2 diabetes) (8.9+/-2.3pg/ml vs. 6.8+/-2.7pg/ml, p=0.001).

    Human trialnormoglycemic offspring of patients with type 2 diabetes2g/day12 weeksn = 50

  5. Fish oil decreases TNF-alpha in bone marrow and splenocytes.

    Animalsin bone marrow and splenocyteshighly purified concentrated fish oilbone marrow and splenocytes12 monthsfemales

  6. Fish oil decreases TNF-alpha in patients with chronic heart failure (SMD = -0.62, 95% CI -1.08 to -0.16, p = 0.009).

    Reviewin patients with chronic heart failure

More on TNF-alpha

HDL cholesterol

upin humans2no changein humans1upin rats1+28%

4 studies
  1. Fish oil increases HDL cholesterol in humans (perimenopausal women receiving nutritional advice adapted to Mediterranean diet) (28.23%).

    Human trialperimenopausal women receiving nutritional advice adapted to Mediterranean dietfish oil1g per day60 daysfemalesn = 98

  2. Fish oil increases HDL cholesterol in humans (P < 0.001).

    Human trial6 months

  3. Fish oil was not clearly linked with HDL cholesterol in humans.

    Humans

  4. Fish oil increases HDL cholesterol in rats.

    Animalsplasma4 weeks

More on HDL cholesterol

Blood pressure

no changein humans2downin humans2

4 studies
  1. Fish oil showed no clear effect on blood pressure in humans.

    Human trial3-weekn = 64

  2. Fish oil decreases blood pressure in humans with resistance exercise training.

    Human trialwith resistance exercise training8 wkfemalesn = 20

  3. Fish oil decreases blood pressure in humans (combined with resistance training) (SBP -7.8 mmHg, DBP -4.5 mmHg, MAP -5.6 mmHg).

    Human trialcombined with resistance training12 weeksn = 28

  4. Fish oil showed no clear effect on blood pressure in humans.

    Human trial12 weeksn = 67

More on Blood pressure

Physical function

upin humans2no changein humans1+7%

3 studies
  1. Fish oil improves physical function in humans (P < 0.001).

    Human trial6 months

  2. Fish oil showed no clear effect on physical function in humans (baseline fish oil supplementation, alone or combined with physical activity).

    Human trialbaseline fish oil supplementation, alone or combined with physical activityaverage of 2.6 yr

  3. Fish oil improves physical function in humans.

    Human trial12 weeksfemales

  4. Fish oil improves physical function in humans (+7%).

    Human trial3g/d12 wkfemalesn = 24

Muscle strength

upin humans3

3 studies
  1. Fish oil improves muscle strength in humans (P < 0.001).

    Human trial6 months

  2. Fish oil improves muscle strength in humans (resistance training) (32.5% vs 8.98%).

    Human trialresistance training98 daysfemalesn = 34

  3. Fish oil improves muscle strength in humans (sarcopenia, with resistance exercise training) (peak torque, 19.46 Nm vs 5.74 Nm, p < 0.001).

    Human trialsarcopenia, with resistance exercise trainingcapsulesskeletal muscle4 g/day14 weeksfemalesn = 34

  4. Fish oil improves muscle strength in humans with strength training.

    Human trialwith strength trainingsupplementation2 g/d90 d or 150 dfemalesn = 45

Mortality

downin humans1downin mice1downin rats1HR 0.77

3 studies
  1. Fish oil decreases mortality in humans (maintenance hemodialysis) (HR 0.77, 95% CI 0.65 to 0.90).

    Human trialmaintenance hemodialysis4 g daily3.5 yearsn = 1,228

  2. Fish oil decreases mortality in rats.

    Animalsmales

  3. Fish oil decreases mortality in mice (lupus nephritis).

    Animalslupus nephritis

All 295

What is fish oil linked with?

45

Studies link fish oil with 45 measures, most often cardiovascular disease (4 studies), myocardial infarction (2) and stroke (2).

Cardiovascular disease

downin humans3downin reviews1HR 0.56–0.93

4 studies
  1. Fish oil lowers the risk of cardiovascular disease in humans (maintenance hemodialysis) (HR 0.57, 95% CI 0.47 to 0.70, P<0.001).

    Human trialmaintenance hemodialysis4 g daily3.5 yearsn = 1,228

  2. Fish oil is linked with a lower risk of cardiovascular disease in humans (no CVD or cancer at baseline) (HR 0.93, 95% CI 0.90 to 0.96).

    Humansno CVD or cancer at baselinen = 427,678

  3. Fish oil lowers the risk of cardiovascular disease in humans (hemodialysis-dependent CKD) (-44%, HR 0.56, 95% CI 0.46-0.68).

    Reviewhemodialysis-dependent CKD

  4. Fish oil lowers the risk of cardiovascular disease (dyslipidemia).

    Reviewdyslipidemia

More on Cardiovascular disease

Myocardial infarction

downin humans2HR 0.52–0.56

2 studies
  1. Fish oil lowers the risk of myocardial infarction in humans (maintenance hemodialysis) (HR 0.56, 95% CI 0.40 to 0.80).

    Human trialmaintenance hemodialysis4 g daily3.5 yearsn = 1,228

  2. Fish oil lowers the risk of myocardial infarction in humans (hemodialysis-dependent CKD) (-48%, HR 0.52, 95% CI 0.34-0.78).

    Reviewhemodialysis-dependent CKD

More on Myocardial infarction

Stroke

downin humans2HR 0.37

2 studies
  1. Fish oil lowers the risk of stroke in humans (maintenance hemodialysis) (HR 0.37, 95% CI 0.18 to 0.76).

    Human trialmaintenance hemodialysis4 g daily3.5 yearsn = 1,228

  2. Fish oil is linked with a lower risk of stroke in diabetic patients (aHR = 0.123; 95% CI 0.016-0.930).

    Humansin diabetic patientsn = 3,652

More on Stroke

Cardiovascular mortality

downin humans2HR 0.65

2 studies
  1. Fish oil is linked with a lower risk of cardiovascular mortality in humans (type 2 diabetes with better CVH (LE8 score ≥55)) (HR: 0.65; 95% CI: 0.51, 0.84).

    Humanstype 2 diabetes with better CVH (LE8 score ≥55)13.7 yn = 19,003

  2. Fish oil is associated with cardiovascular mortality in humans (cardiometabolic multimorbidity) (19% lower risk; 95% CI 0.72–0.90; P < 0.001).

    Humanscardiometabolic multimorbidity12.03 years of follow-up67.9% mensn = 30,068

Dementia

downin humans2HR 0.76–0.93

2 studies
  1. Fish oil is linked with a lower risk of dementia in humans (diabetic patients) (HR 0.76, 95% CI 0.60-0.98).

    Humansdiabetic patientsmean duration of 7.7 yearsn = 16,061

  2. Fish oil is linked with a lower risk of dementia in humans (HR 0.93 [0.89-0.97], -7%).

    Humansmedian 9.25 yearsn = 440,750

More on Dementia

Mortality

downin humans2HR 0.87

2 studies
  1. Fish oil is associated with mortality in humans (cardiometabolic multimorbidity) (17% lower risk; 95% CI 0.78–0.88).

    Humanscardiometabolic multimorbidity12.03 years of follow-up67.9% mensn = 30,068

  2. Fish oil is linked with a lower risk of mortality in humans (no CVD or cancer at baseline) (HR 0.87, 95% CI 0.83 to 0.90).

    Humansno CVD or cancer at baselinen = 427,678

All-cause dementia

downin humans2HR 0.87–0.91

2 studies
  1. Fish oil is linked with a lower risk of all-cause dementia in humans (multivariable adjusted models) (HR 0.91 [0.84-0.97]).

    Humansmultivariable adjusted modelsmedian follow-up 11.7 yearsn = 211,094

  2. Fish oil is linked with a lower risk of all-cause dementia in humans (HR 0.87 (95% CI 0.79-0.96)).

    Humans

More on All-cause dementia

Cancer

downin humans1no changein humans1HR 0.96–0.97

1 study
  1. Fish oil is linked with a lower risk of cancer in participants who consumed fatty fish less than two times per week (HR = 0.96, 95% CI = 0.94-0.99).

    Humansin participants who consumed fatty fish less than two times per week

  2. Fish oil is associated with cancer in humans (HR = 0.97, 95% CIs = 0.95-1).

    Humansn = 470,804

More on Cancer

Aortic valve stenosis

downin humans1HR 0.9

1 study
  1. Fish oil is linked with a lower risk of aortic valve stenosis in humans (HR 0.90, 95% CI 0.86–0.95).

    Humansmedian 13.8 yearsn = 501,083

    Fish oil use linked to lower risk of aortic valve narrowing

    ESC Congress 2026 abstract

More on Aortic valve stenosis

Cognitive function

downin humans1

1 study
  1. Fish oil is associated with cognitive function in humans (mediated by FDG-PET hypometabolism).

    Reviewmediated by FDG-PET hypometabolism

Carotid plaque

downin humans1

1 study
  1. Fish oil lowers the risk of carotid plaque in patients with low genetic risk for remnant cholesterol (P for interaction = 0.008; FDR = 0.056).

    Human trialin patients with low genetic risk for remnant cholesterol3.0 g/day14 month

More on Carotid plaque

Major mobility disability

downin humans1HR 0.78

1 study
  1. Fish oil lowers the risk of major mobility disability in humans after adjusting for confounders (HR 0.78 (95% CI 0.64-0.96)).

    Human trialafter adjusting for confoundersaverage of 2.6 yr

More on Major mobility disability

Oxylipin profile

mixedin humans1

1 study
  1. Fish oil is associated with oxylipin profile in humans (White postmenopausal women).

    Human trialWhite postmenopausal womenfish oil supplement of n-3 PUFAserum720mg 20:5n3+480mg 22:6n3/d6 monthsfemalesn = 20

More on Oxylipin profile

Lipid metabolism-related gene expression

mixedin humans1

1 study
  1. Fish oil is associated with lipid metabolism-related gene expression in humans (normo- and dyslipidemic men).

    Human trialnormo- and dyslipidemic mencapsuleswhole blood cellssix fish oil capsules per day, providing 1.14 g docosahexaenoic acid and 1.56 g eicosapentaenoic acidtwelve weeksmales

Lipids

mixedin humans1

1 study
  1. Fish oil is associated with lipids in humans (lupus nephritis).

    Human triallupus nephritis2 years 10 weeksn = 26

More on Lipids

All 45

Has fish oil been tested in people?

16 of 116 about aging

Yes: 127 trials and 45 observational studies in people have been published, and 101 trials are registered.

Every condition in trials

40 of 114

Stopped

  • NCT00791089TerminatedAtrial fibrillation

    unable to secure funding and long term follow up

  • NCT01548534TerminatedBreast neoplasm

    Judicial liquidation of the society providing dietary supplementation.

  • NCT01764308TerminatedAcne

    insufficient staff to complete recruitment

  • NCT01565278TerminatedHyperphagia

    No more eligible patients could be identified.

  • NCT01769092TerminatedEpilepsy

    Unable to recruit participants

  • NCT01259284TerminatedColorectal neoplasm

    Terminated due to low accrual.

All 13

Who is developing fish oil?

1 company: GCP-Service International West.

Companies
  • GCP-Service International WestPhase 2intensive care unit, coronary artery bypass grafting

Trial sponsors

Funding

1 grant since 2023

Gouvernement du Canada | Canadian Institutes of Health ResearchCA$1.1M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Independent labs report longer lifespans in female lupus-prone mice given fish oil; oxidative-stress results point both ways in mice and humans. One registered trial concerns aging; 38 trials across uses ended over a year ago without posted results or citing papers. Some authors work at Nestec or Zora Biosciences, and a paper declares Zora Biosciences ties.

  2. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 3Feb 2026: 1Mar 2026: 4Apr 2026: 0May 2026: 1Jun 2026: 2Jul 2026: 0Aug 2026: 2Sep 2026: 3Oct 2026: 3Nov 2026: 222 papers in 12 months
ESC Congress 2026 Abstract

Fish oil use linked to lower risk of aortic valve narrowing

Among 501,083 UK Biobank participants, fish oil supplementation was associated with a 10% lower relative risk of aortic valve narrowing than non-use.Among 501,083 UK Biobank participants, fish oil supplementation was associated with a 10% lower relative risk of aortic valve narrowing than non-use.

Cohort · 501,083 peoplePopulations

See all 274 papers on fish oil